ENDO GIA
Report
- Report Number
- 1219930-2022-04782
- Event Type
- Injury
- Date Received
- December 7, 2022
- Date of Event
- February 14, 2022
- Report Date
- December 7, 2022
- Manufacturer
- COVIDIEN LP LLC NORTH HAVEN
- Product Code
- GDW
- UDI-DI
- 20884523003250
- PMA / PMN Number
- K111825
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- OTHER
Narratives
CONCOMITANT MEDICAL PRODUCTS: EGIA60AXT EGIA60 ARTIC EXTRA THICKSULU (LOT#: UNKNOWN); UNKNOWN ENDO GIA INSTRUMENT (LOT#: UNKNOWN) ARTICLE: ROBOTIC VERSUS OPEN PANCREATIC SURGERY: A PROPENSITY SCORE-MATCHED COST-EFFECTIVENESS ANALYSIS SOURCE: SPRINGERLINK AND PUBMED. LANGENBECK'S ARCHIVES OF SURGERY (2022) 407:1923¿1933, HTTPS://DOI.ORG/10.1007/S00423-022-02471-2 RECEIVED: 5 OCTOBER 2021 / ACCEPTED: 14 FEBRUARY 2022. MEDTRONIC IS SUBMITTING THIS REPORT TO COMPLY WITH FDA REPORTING REGULATIONS UNDER 21 CFR PARTS 4 AND 803. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION AND HAS PROVIDED AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY ¿DEFECTS¿ OR HAS ¿MALFUNCTIONED¿. THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REGULATORY REPORTING. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE THEM BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT.
ACCORDING TO THE LITERATURE, A RETROSPECTIVE STUDY AIMED TO COMPARE PATIENTS UNDERGOING OPEN PANCREATIC SURGERY AND ROBOTIC PANCREATIC SURGERY WITH REGARDS TO COST-EFFECTIVENESS BETWEEN 2017 AND 2019. THE STUDY INCLUDED ALL PATIENTS WHO UNDERWENT OPEN OR ROBOTIC PARTIAL PANCREATICODUODENECTOMY, DISTAL PANCREATECTOMY, OR TOTAL PANCREATECTOMY. FOR DISTAL PANCREATECTOMY, CLOSURE OF THE PANCREATIC REMNANT WAS EITHER PERFORMED USING A 60-MM BLACK RELOAD OR ANOTHER TECHNIQUE. FOR OPEN PANCREATIC SURGERY, THE PANCREAS WAS DISSECTED BY ELECTROCAUTERY OR A 60-MM BLACK RELOAD. 282 PATIENTS UNDERWENT OPEN SURGERY AND 92 PATIENTS UNDERWENT ROBOTIC SURGERY. POSTOPERATIVE COMPLICATIONS INCLUDED: POSTOPERATIVE PANCREATIC FISTULA AND POSTOPERATIVE PANCREATIC HEMORRHAGE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1469929 | ENDO GIA | STAPLE, IMPLANTABLE | GDW | COVIDIEN LP LLC NORTH HAVEN | EGIA60AXT | 20884523003250 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Female | Required Intervention |